Upadacitinib Nitroso Impurity 4 - Request Quote
Upadacitinib Nitroso Impurity 4
| SZ CAT No: | SZ-U005064 |
| CAS No | NA |
| Mol.F. | C14H16N6O |
| Mol.Wt. | 284.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Upadacitinib Nitroso Impurity 4 is chemically 8-((3R,4S)-4-Ethyl-1-nitrosopyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine. Upadacitinib Nitroso Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Nitroso Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Upadacitinib Nitroso Impurity 4
Purchase Upadacitinib Nitroso Impurity 4
Upadacitinib Nitroso Impurity 4 suppliers
Upadacitinib Nitroso Impurity 4 manufacturers
Upadacitinib Nitroso Impurity 4 price
Order Upadacitinib Nitroso Impurity 4
Enquire Upadacitinib Nitroso Impurity 4
Upadacitinib Nitroso Impurity 4 cost
Upadacitinib Nitroso Impurity 4 Supplier
Upadacitinib Nitroso Impurity 4 Distributor
Upadacitinib Nitroso Impurity 4 for Method Validation
Upadacitinib Reference Standard
Upadacitinib Nitroso Impurity 4 for ANDA Filing
Upadacitinib Nitroso Impurity 4 for Forced Degradation Studies
Upadacitinib Nitroso Impurity 4 Identification Standards
Upadacitinib Nitroso Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.